(Total Views: 451)
Posted On: 12/20/2019 2:39:50 PM
Post# of 154851
This week CYDY announced major milestone news - an $87.5 million licensing deal for commercializing Leronlimab to treat HIV.
CYDY is now officially entering "SUPER STOCK" territory with it's stock price break-out and potential for even bigger upside in the months ahead...
Check out CYDY's November 14, 2019 NEXT SUPER STOCK conference presentation.
CEO, Nader Purhassan, Ph.D., will be doing a follow-up presentation on January 15, 2020. Click https://register.gotowebinar.com/register/364...0964279053 to join the livestream, and participate in Q&A.
CYDY is now officially entering "SUPER STOCK" territory with it's stock price break-out and potential for even bigger upside in the months ahead...
Check out CYDY's November 14, 2019 NEXT SUPER STOCK conference presentation.
CEO, Nader Purhassan, Ph.D., will be doing a follow-up presentation on January 15, 2020. Click https://register.gotowebinar.com/register/364...0964279053 to join the livestream, and participate in Q&A.
(4)
(0)
